BlossomHill Therapeutics: Funding, Investors & Team (Oct 2026)
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
BlossomHill Therapeutics has raised $155M across 2 funding rounds on record, the most recent a Series B of $84.0M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BlossomHill Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
BlossomHill Therapeutics Funding Rounds
BlossomHill Therapeutics raised $71.0M in a Series A announced in Mar 2021.
4.8 years later, a Series B of $84.0M was announced in Dec 2025.
BlossomHill Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
BlossomHill Therapeutics Funding Compared to Other Biotechnology Startups
BlossomHill Therapeutics' latest round of $84.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BlossomHill Therapeutics in Biotechnology and San Diego
Companies Similar to BlossomHill Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
BlossomHill Therapeutics Funding FAQs
What does BlossomHill Therapeutics do?
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
How much funding has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $155M across 2 rounds on record. The most recent is a Series B of $84.0M announced in Dec 2025.
When did BlossomHill Therapeutics last raise funding?
BlossomHill Therapeutics' most recent funding round on record is a Series B of $84.0M, announced in Dec 2025.
Who founded BlossomHill Therapeutics?
FundedIQ lists Y Peter Li (Founder) at BlossomHill Therapeutics.
Who is the CEO of BlossomHill Therapeutics?
Jingrong Jean Cui is listed as CEO at BlossomHill Therapeutics.
Where is BlossomHill Therapeutics headquartered?
BlossomHill Therapeutics is based in San Diego, California, United States.
How many employees does BlossomHill Therapeutics have?
BlossomHill Therapeutics is in the 1-10 employee band.
How does BlossomHill Therapeutics' funding compare to other Biotechnology startups?
BlossomHill Therapeutics' latest round of $84.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BlossomHill Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BlossomHill Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.